Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011
William M. Lee, R. Todd Stravitz, Anne M. Larson – 27 December 2011
William M. Lee, R. Todd Stravitz, Anne M. Larson – 27 December 2011
Antonella Pellicoro, Rebecca L. Aucott, Prakash Ramachandran, Andrew J. Robson, Jonathan A. Fallowfield, Victoria K. Snowdon, Stephen N. Hartland, Madeleine Vernon, Jeremy S. Duffield, R. Christopher Benyon, Stuart J. Forbes, John P. Iredale – 27 December 2011 – Elastin has been linked to maturity of liver fibrosis. To date, the regulation of elastin secretion and its degradation in liver fibrosis has not been characterized. The aim of this work was to define elastin accumulation and the role of the paradigm elastase macrophage metalloelastase (MMP‐12) in its turnover during fibrosis.
Cynthia D. Guy, Ayako Suzuki, Marzena Zdanowicz, Manal F. Abdelmalek, James Burchette, Aynur Unalp, Anna Mae Diehl, for the NASH CRN – 27 December 2011 – The Hedgehog (HH)‐signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate.
Qiuwei Pan, Petra E. de Ruiter, Herold J. Metselaar, Jaap Kwekkeboom, Jeroen de Jonge, Hugo W. Tilanus, Harry L.A. Janssen, Luc J.W. van der Laan – 27 December 2011 – Mycophenolic acid (MPA) is a highly effective immunosuppressant that has broad antiviral activity against different viruses and can act in synergy with interferon‐α (IFN‐α) on hepatitis C virus (HCV) replication. MPA is a potent inosine monophosphate dehydrogenase (IMPDH) inhibitor but the antiviral mechanisms are less understood.
Ursula Ehmer, Sandra Kalthoff, Bastian Fakundiny, Brigitte Pabst, Nicole Freiberg, Ronald Naumann, Michael P. Manns, Christian P. Strassburg – 27 December 2011 – Gilbert syndrome (GS) is characterized by intermittent unconjugated hyperbilirubinemia without structural liver damage, affecting about 10% of the white population. In GS the UGT1A1*28 variant reduces bilirubin conjugation by 70% and is associated with irinotecan and protease inhibitor side effects. The aim of this study was to characterize potential in vivo consequences of UGT1A gene variability in GS.
E. Jenny Heathcote – 27 December 2011
Guoyuan Liu, Songmin Jiang, Chenji Wang, Wei Jiang, Zulong Liu, Chao Liu, Hexige Saiyin, Xianmei Yang, Suqin Shen, Deke Jiang, Ping Zhou, Dingding Han, Xiaohui Hu, Qing Yi, Long Yu – 27 December 2011 – Activation of β‐catenin, the central effector of the canonical wingless‐type (Wnt) pathway, has been implicated in hepatocellular carcinoma (HCC). However, the transcription regulation mechanism of the β‐catenin gene in HCC remains unknown. Here we report that human zinc finger protein 191 (ZNF191) is a potential regulator of β‐catenin transcription.
Ian A. Rowe, Matthew J. Armstrong, Diarmaid D. Houlihan – 27 December 2011
Bruno Sangro, for the European Network on Radioembolization With Yttrium‐90 Resin Microspheres – 24 December 2011
Tung Ming Leung, Yongke Lu, Wei Yan, José A. Morón‐Concepción, Stephen C. Ward, Xiaodong Ge, Laura Conde de la Rosa, Natalia Nieto – 24 December 2011 – Argininosuccinate synthase (ASS) is the rate‐limiting enzyme in both the urea and the L‐citrulline/nitric oxide (NO·) cycles regulating protein catabolism, ammonia levels, and NO· generation.